An overview of current regulations and anticipated changes in the emerging psychedelics therapy landscape.
A Shifting Legal Landscape
The legal status of psychedelics is evolving rapidly across the United States. While these substances remain classified as Schedule I under federal law, several states have moved to decriminalize or create therapeutic frameworks. Michigan is watching these developments closely, with increasing interest from both medical professionals and entrepreneurs.
Current Legal Status in Michigan
As of 2024, psychedelics including psilocybin, LSD, and MDMA remain illegal in Michigan under state law. However, several municipalities have taken decriminalization steps:
- Ann Arbor – In 2020, became the first Michigan city to decriminalize entheogenic plants and fungi
- Detroit – Followed with similar decriminalization in 2021
- Ferndale, Hazel Park, and others – Have also adopted decriminalization resolutions
It's important to note that decriminalization is not legalization. Manufacturing, distribution, and possession can still result in charges under state and federal law.
Federal Developments to Watch
The FDA has designated psilocybin as a "Breakthrough Therapy" for treatment-resistant depression, signaling potential future approval for therapeutic use. Similarly, MDMA-assisted therapy for PTSD has shown promising results in Phase 3 clinical trials.
If the FDA approves these treatments, Michigan businesses and healthcare providers will need to understand how to operate within both federal and state regulatory frameworks.
State-Level Legislative Activity
Michigan legislators have introduced bills exploring:
- Creation of advisory committees to study psychedelic therapy
- Therapeutic use frameworks similar to those in Oregon and Colorado
- Research exemptions for academic institutions
While none have become law yet, momentum is building for some form of regulated access.
What This Means for Entrepreneurs and Investors
Those interested in entering the psychedelics industry should be prepared for:
- Significant regulatory complexity – Far more than cannabis, given federal scheduling and medical use implications
- Long development timelines – Therapeutic frameworks take years to implement
- High barriers to entry – Expect rigorous licensing requirements once legal frameworks exist
- Parallel tracks – Medical/therapeutic vs. wellness/retreat models
Planning for the Future
While operating a psychedelics business in Michigan is not currently legal, forward-thinking entrepreneurs can:
- Monitor legislative developments at state and federal levels
- Study frameworks from Oregon and Colorado
- Build relationships with research institutions
- Develop business plans that can adapt to multiple regulatory scenarios
- Consult with attorneys experienced in emerging drug policy
Interested in Psychedelics Law Developments?
Goldstein PLLC monitors this evolving area and can help you prepare for future opportunities.
Schedule a Consultation